Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: an in vivo 11C-raclopride PET study.

Experimental Neurology
Marios PolitisD J Brooks

Abstract

A mild to moderate reduction in dopamine, noradrenaline and serotonin levels alongside a progressive loss of hypocretin cells and melanin hormone concentrating cells has been reported in the hypothalamus of PD at postmortem. Hypothalamic uptake of (18)F-dopa PET, an in vivo marker of dysfunction of monoaminergic neurons, is also significantly reduced in these patients. These data indicate a general impairment of hypothalamic function in PD. Dopamine receptors play an important role in the regulation of hypothalamic pathways. To date, possible changes in hypothalamic D(2) receptor availability have not been investigated in PD. The objective in this study was to assess dopamine D(2) receptor availability in hypothalamus of patients with idiopathic Parkinson's disease (PD) using positron emission tomography (PET) with (11)C-raclopride (RAC). We evaluated D(2) binding in RAC PET images of 14 PD patients using both region of interest (ROI) analysis and a voxel based approach. ROIs for the hypothalamus were traced on the subject's MRI co-registered to the PET image. (11)C-raclopride binding potentials (BP) for hypothalamus were obtained by applying ROIs onto parametric images. Findings were compared with those of 9 normal controls. W...Continue Reading

References

Feb 1, 1978·Annals of Neurology·J W Langston, L S Forno
May 1, 1984·Neurology·F Javoy-AgidY Agid
Jan 14, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·E V Gurevich, J N Joyce
Jan 28, 2004·Annual Review of Psychology·Jerome M Siegel
Apr 20, 2004·Brain : a Journal of Neurology·Christoph ScherflerPaola P Piccini
Jun 28, 2005·The European Journal of Neuroscience·Michael BubserAriel Y Deutch
Apr 14, 2006·Journal of Neurophysiology·Akihiro YamanakaTakeshi Sakurai
Sep 29, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Christian O AlbertoMichiru Hirasawa
May 2, 2007·Brain : a Journal of Neurology·Rolf FronczekDick F Swaab
May 11, 2007·Brain : a Journal of Neurology·Thomas C ThannickalJerome M Siegel

❮ Previous
Next ❯

Citations

Feb 3, 2012·Journal of Neurology·Marios Politis, Paola Piccini
Mar 5, 2013·Journal of Neural Transmission·K Ray ChaudhuriKapil D Sethi
Nov 9, 2011·The Neurologist·Juan Carlos Martinez-CastrilloAraceli Alonso-Canovas
Sep 21, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S WailkeJ Volkmann
Nov 12, 2014·Nature Reviews. Neurology·Marios Politis
Nov 16, 2013·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Ariel B NeikrugSonia Ancoli-Israel
Mar 22, 2014·Expert Opinion on Investigational Drugs·Livia Dézsi, László Vécsei
Oct 1, 2015·Scientific Reports·Rana Soylu-KucharzÅsa Petersén
Mar 15, 2014·Journal of Neurology·Flavia NiccoliniMarios Politis
Feb 28, 2014·The Tohoku Journal of Experimental Medicine·Hui ZhangPiu Chan
Jun 20, 2015·Journal of Movement Disorders·Hye Mi Lee, Seong-Beom Koh
Jun 1, 2016·Frontiers in Aging Neuroscience·Isobel T French, Kalai A Muthusamy
Nov 12, 2016·Journal of Advanced Pharmaceutical Technology & Research·K G PrakashArchana Rajagopalan
Nov 29, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Eduardo De Pablo-FernandezThomas T Warner
Jan 27, 2010·Journal of Geriatric Psychiatry and Neurology·David G GunnSimon J G Lewis
Sep 27, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·M L Mamalyga, L M Mamalyga
May 29, 2009·BMC Medical Research Methodology·Stanley E LazicRoger A Barker
Feb 19, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Karin D van DijkYsbrand D van der Werf
May 9, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Holger HonigK Ray Chaudhuri
Jul 16, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Marios PolitisPaola Piccini
Mar 15, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·David P BreenRoger A Barker
May 7, 2009·Lab on a Chip·Arkadij M Elizarov
Dec 21, 2016·Neuroscience Bulletin·Siyue LiChun-Feng Liu
Oct 17, 2018·Frontiers in Neurology·Tayyabah YousafMarios Politis
Jan 4, 2019·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Jeanette M Metzger, Marina E Emborg
Jul 14, 2017·Journal of Neural Transmission·Joseph ClassenAlexander Storch
Sep 25, 2017·Neuroscience Bulletin·Sharvari LotankarLokesh K Bhatt
Apr 20, 2017·Frontiers in Cellular Neuroscience·Kirill S KorshunovPaul Q Trombley
Jan 15, 2019·Movement Disorders Clinical Practice·Antonio P StrafellaUNKNOWN IPMDS‐Neuroimaging Study Group
Dec 25, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Sang-Won YooJoong-Seok Kim
Sep 15, 2020·Journal of Parkinson's Disease·Seok Jong ChungYoung H Sohn
Jan 16, 2019·Journal of Neural Transmission·Fanni F GeiblWolfgang H Oertel
Aug 28, 2020·NeuroImage·Benjamin BillotJuan Eugenio Iglesias
Oct 17, 2018·Seminars in Nuclear Medicine·Baijayanta Maiti, Joel S Perlmutter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.